These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36584135)

  • 1. Association between myopia progression and quantity of laser treatment for retinopathy of prematurity.
    Hwang ES; Kassem IS; Allozi R; Kravets S; Al-Kirwi KY; Hallak JA; Costakos DM
    PLoS One; 2022; 17(12):e0279898. PubMed ID: 36584135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes.
    Katoch D; Sanghi G; Dogra MR; Beke N; Gupta A
    Indian J Ophthalmol; 2011; 59(6):423-6. PubMed ID: 22011484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of myopia in laser-treated ROP infants: prematurity or laser photocoagulation?
    Kıran Yenice E; Kara C
    Int Ophthalmol; 2023 May; 43(5):1453-1458. PubMed ID: 36149616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation.
    Wiecek E; Akula JD; Vanderveen DK; Mantagos IS; Wu C; Curran AL; De Bruyn H; Peterson B; Fulton AB
    Am J Ophthalmol; 2022 Aug; 240():252-259. PubMed ID: 35367438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Quinn GE; Dobson V; Kivlin J; Kaufman LM; Repka MX; Reynolds JD; Gordon RA; Hardy RJ; Tung B; Stone RA
    Ophthalmology; 1998 Jul; 105(7):1292-300. PubMed ID: 9663236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity.
    Mori Y; Arima M; Ueda E; Fujiwara K; Seki E; Nakama T; Tsukamoto S; Akiyama M; Sonoda KH
    Eye (Lond); 2021 Oct; 35(10):2820-2825. PubMed ID: 33257802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
    Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
    Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes.
    Axer-Siegel R; Maharshak I; Snir M; Friling R; Ehrlich R; Sherf I; Shalev B; Sirota L; Weinberger D
    Retina; 2008 Jun; 28(6):839-46. PubMed ID: 18536600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser photocoagulation (810 nm diode) for threshold retinopathy of prematurity: a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone.
    Uparkar M; Sen P; Rawal A; Agarwal S; Khan B; Gopal L
    Int Ophthalmol; 2011 Feb; 31(1):3-8. PubMed ID: 21194006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.
    Gunay M; Celik G; Ovali F; Yetik H; Aktas A; Gunay BO
    Int Ophthalmol; 2015 Feb; 35(1):27-35. PubMed ID: 25381161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractive Changes among Diode Laser-treated Retinopathy of Prematurity Patients: A Retrospective Study.
    Alqurashi L; Alfaraidi A; Almahmoudi F; Danish E; Hadrawi M
    Middle East Afr J Ophthalmol; 2023; 30(1):37-43. PubMed ID: 38435111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.
    Geloneck MM; Chuang AZ; Clark WL; Hunt MG; Norman AA; Packwood EA; Tawansy KA; Mintz-Hittner HA;
    JAMA Ophthalmol; 2014 Nov; 132(11):1327-33. PubMed ID: 25103848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the number of laser applications for ROP treatment influence the degree of myopia?
    Inoue T; Asaoka R; Hashimoto Y; Kitamoto K; Kitano M; Fujita A; Azuma K; Yamamoto K; Nagahara M; Kadonosono K; Obata R
    Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):317-322. PubMed ID: 32978662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.
    Lok JYC; Yip WWK; Luk ASW; Chin JKY; Lau HHW; Young AL
    Int Ophthalmol; 2018 Feb; 38(1):163-169. PubMed ID: 28054213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the severity of refractive error dependent on the quantity and extent of retinal laser ablation for retinopathy of prematurity?
    Young-Zvandasara T; Popiela M; Preston H; Seow E; Watts P
    Eye (Lond); 2020 Apr; 34(4):740-745. PubMed ID: 31554947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study.
    Chou YB; Wang AG; Yang HY; Chen KJ; Yang CS
    Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3809-3816. PubMed ID: 35729410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity.
    McLoone EM; O'Keefe M; McLoone SF; Lanigan BM
    J AAPOS; 2006 Oct; 10(5):454-9. PubMed ID: 17070482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinopathy of prematurity in infants weighing less than 500 grams at birth enrolled in the early treatment for retinopathy of prematurity study.
    Wheeler DT; Dobson V; Chiang MF; Bremer DL; Gewolb IH; Phelps DL; Hardy RJ; Good WV; Fellows R; Tung BP; Palmer EA
    Ophthalmology; 2011 Jun; 118(6):1145-51. PubMed ID: 21211840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractive status of Chinese with laser-treated retinopathy of prematurity.
    Ruan L; Shan HD; Liu XZ; Huang X
    Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S3-9. PubMed ID: 25756334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review.
    Tan QQ; Christiansen SP; Wang J
    PLoS One; 2019; 14(12):e0225643. PubMed ID: 31790445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.